Skip to content
‹ Back to IndustriesSciences

Will Solar Power Lead to the Future of Space Exploration?

Highlights The Planetary Society launched the second-ever solar sail spacecraft last month, LightSail 2. The unique design could transform deep space exploration as it does not need fuel or expensive rockets. The spacecraft operates using only the power of photons from the Sun. LightSail 2 deploys a sail made from Mylar that unfolds to almost…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · B2bScienceSolarSpace Exploration
Share

Key takeaways

01

Highlights The Planetary Society launched the second-ever solar sail spacecraft last month, LightSail 2.

02

The unique design could transform deep space exploration as it does not need fuel or expensive rockets.

03

The spacecraft operates using only the power of photons from the Sun.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Highlights

  • The Planetary Society launched the second-ever solar sail spacecraft last month, LightSail 2.
  • The unique design could transform deep space exploration as it does not need fuel or expensive rockets.
  • The spacecraft operates using only the power of photons from the Sun.
  • LightSail 2 deploys a sail made from Mylar that unfolds to almost 300 square feet
  • The spacecraft is expect to orbit for about a year before falling back to Earth’s atmosphere.
  • The organization is hopeful that the technology will be applied to missions searching for life in the solar system.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Uncountable adds cleanroom monitoring aimed at linking results into QMS, CAPA and batch-traceability workflows

Uncountable adds cleanroom monitoring aimed at linking results into QMS, CAPA and batch-traceability workflows

Uncountable’s monitoring module maps sampling points and, per Cleanroom Technology, can tie results into CAPA and batch/training traceability when linked records are populated.

  • 01Proving a sample was taken is the easy part of an Annex 1 inspection; showing what the result means for the batch filled in that room depends on how monitoring records connect to CAPA, batch and training files.
  • 02Uncountable's module records whether a cleanroom was at rest or in operation for every sample, so results can be trended by room state, method and location instead of reviewed one excursion at a time.
  • 03Before buying any monitoring software, ask which linked records a site will actually populate, how the system behaves without connectivity, and how instrument telemetry gets in, since Uncountable does not ingest sensor data natively.

Nov 19, 2026

PharmaLogic buys Lantheus' New Jersey radiopharma plant with a supply deal attached

PharmaLogic buys Lantheus' New Jersey radiopharma plant with a supply deal attached

PharmaLogic is buying Lantheus' contract manufacturing unit and Springfield, New Jersey radiopharmaceutical plant, plus a long-term deal to make lutetium Lu 177 dotatate for Lantheus. Radioligand developers looking for capacity should ask how much of the plant's capacity is still open.

  • 01A long-term supply contract attached to a plant sale could help keep costly hot-cell capacity in use. According to Grand View Research, committed supply agreements are among the tools that help providers align capital spending with customer development milestones.
  • 02Radioligand developers evaluating PharmaLogic's Agilera unit should ask how much Springfield capacity the lutetium Lu 177 dotatate contract will take up and how much is left for new programs.
  • 03Two pending transactions shape what to watch next: regulatory review and closing conditions for the PharmaLogic purchase, and Curium’s August offer of upward of $8 billion for Lantheus, which is still closing.

Nov 18, 2026

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA agreed to buy Rapid Micro Biosystems, maker of the Growth Direct microbial testing platform, for $0.75 per share in cash. The deal turns a 2025 distribution partnership into ownership. Growth Direct instruments, consumables and software would then come from the company that already sells QC products to pharma labs, pending a December 2026 close.

  • 01Growth Direct shifts from a Merck-distributed product, under a February 2025 agreement, to a Merck-owned one inside a QC portfolio that spans environmental monitoring, in-process and release testing.
  • 02For labs that already run Growth Direct alongside MilliporeSigma QC products, the useful question is how the platform's digital sample records will connect to the rest of that workflow after close.
  • 03The next date to watch is the Schedule TO filing that opens the tender offer; closing targeted for December 2026 requires a majority of Rapid Micro’s voting shares to be tendered.

Nov 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512